Trial Profile
Phase1 Clinical Trial of OTS11101 in Subjects with Solid Tumors.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Dec 2014
Price :
$35
*
At a glance
- Drugs OCV 101 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 12 Jan 2011 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 10 Nov 2009 New trial record